Company Filing History:
Years Active: 1998
Title: Michael Auguello: Innovator in Pharmaceutical Excipients
Introduction
Michael Auguello is a notable inventor based in Marlboro, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of excipient compositions. His innovative work has led to the creation of a patented product that enhances the effectiveness of pharmaceutical tablets.
Latest Patents
Michael holds a patent for co-processed products, specifically for particulate pharmaceutical tablet excipient compositions. This patent describes compositions comprising co-processed microcrystalline cellulose and particulate USP calcium carbonate. The unique particle size distribution of 7 to 22 µm, along with the specific ratio of calcium carbonate to microcrystalline cellulose ranging from 70:30 to 90:10, showcases his innovative approach to improving pharmaceutical formulations. He has 1 patent to his name.
Career Highlights
Michael Auguello is associated with FMC Corporation, where he applies his expertise in pharmaceutical development. His role at the company allows him to work on cutting-edge projects that aim to enhance the quality and efficacy of pharmaceutical products. His dedication to innovation has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Michael has collaborated with esteemed colleagues such as Thomas A. Ruszkay and George E. Reier. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in pharmaceutical technology.
Conclusion
Michael Auguello's contributions to the field of pharmaceuticals through his innovative patent and collaborative efforts highlight his commitment to advancing the industry. His work continues to influence the development of effective pharmaceutical excipients, making a lasting impact on healthcare.